newsfilter.io

Lance Price

Showing 1–5 of 5 transcripts.

  1. Milken Institute1h 2m

    Outsmarting Superbugs: What Are the Alternatives?

    Margaret Hamburg, Matthew Hepburn, Peter Jackson, Nancy Knight, Jeanette Mucha, Peter Piot, Peggy Hamburg, David Wallace, Lance Price

    Global leaders and organizations including the WHO, CDC, and the U.K. government are coordinating a multi-faceted response to antimicrobial resistance, which threatens to cause 10 million annual deaths by 2050 and mimic the 2008 financial crisis through massive economic losses. Innovative initiatives such as the CDC's AMR Challenge, Carb-X's $80 million funding for 40 development projects, and the U.K.'s "pull incentive" trial aim to revitalize the antibiotic pipeline by supporting SMEs and rewarding disease prevention rather than sales volume. Despite these advances, experts warn that rigid intellectual property laws, inadequate wastewater treatment, and capital gaps in microbiome startups hinder the deployment of new therapies needed to combat untreatable superbugs like drug-resistant tuberculosis.

  2. Milken Institute56 min

    Superbugs: Avoiding an Existential Threat to Humanity

    Esther Krofah, Valeria Bortolaia, Ron Daniels, Peter Jackson, Peter Piot, Lance Price, Sneha Kemka

    This analysis details the critical global escalation of antimicrobial resistance, which currently causes 700,000 annual deaths and threatens to reach 10 million by 2050 without urgent intervention. The event highlights a pharmaceutical market failure where major drug withdrawals have shifted innovation to undercapitalized SMEs, necessitating new economic incentives like the UK's pilot pull mechanism to fund R&D. Strategic solutions prioritize infection control, agricultural bans on growth promoters, and precision diagnostics to bridge the gap between scientific discovery and clinical application.

  3. Milken Institute58 min

    Disrupting Food: Alternative Proteins Leading to a More Sustainable Future

    Cristina Alesci, Ethan Brown, Jeremy Coller, Uma Valeti, David Levinson, David Rockefeller Jr., Lance Price, Jenny Santee, Jonathan Smiga, Ashley

    Ethan Brown of Beyond Meat and Uma Valenti of Memphis Meats joined Collar Capital's Jeremy Collar to address the environmental and health crises of traditional livestock, proposing plant-based restructuring and cellular agriculture as sustainable alternatives. The panel detailed how these technologies are achieving rapid cost reductions and high consumer acceptance while positioning incumbent factory farms as stranded assets vulnerable to regulatory bans and supply chain failures. Ultimately, the discussion highlighted a strategic shift where major industry players view these innovations as essential partners in mitigating food safety risks and capitalizing on a growing market for high-quality, low-impact protein.

  4. Milken Institute50 min

    Superbugs: Slowing the Spread of Antibiotic-Resistant Bacteria

    Maryn McKenna, Beth Bell, Barry Eisenstein, Lance Price, Zachary Rubin

    Unchecked antimicrobial resistance threatens to cause 10 million global deaths and $100 trillion in economic losses by 2050, driven by stalled pharmaceutical innovation, agricultural misuse, and rapid pathogen spread. Critical failures in current stewardship and reimbursement models have allowed superbugs like CRE and MCR-1 to emerge, undermining essential medical procedures from cancer treatment to organ transplantation. Urgent interventions including international data sharing, regulatory incentives for novel antibiotics, and a shift in clinical and agricultural practices are now essential to prevent a post-antibiotic era.

  5. Milken Institute51 min

    The 2014 Atlanta Summit - - Race We Can't Afford to Lose: Outsmarting Superbugs

    Larry Brilliant, Beth Bell, Victoria Nahum, Lance Price, Andy von Eschenbach

    Public health leaders convened to address the critical obsolescence of U.S. disease surveillance technology, which currently lags behind the rapid, cost-effective capabilities of Advanced Molecular Detection required to combat antimicrobial resistance and food-borne threats. Panelists detailed the catastrophic societal costs of preventable infections, including specific cases where delayed diagnostics contributed to mortality, while arguing that federal inaction represents the single greatest immediate risk to national security and public safety. The discussion concluded with a unified call for mandatory antibiotic stewardship, standardized genomic testing, and medical diplomacy to secure global health infrastructure before emerging pathogens outpace current diagnostic limitations.